Toshiba Medical said that this acquisition brings in-house the development of 3D volume rendering and advanced visualization capabilities for all its modalities. The advanced visualization imaging system (AVIS)
The new corporate headquarters, located in Columbia, South Carolina, serves as the primary distribution center and provides more than threefold the office space and warehousing capabilities of the
Soliris is said to be the first therapy approved in Canada for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). Soliris was approved under priority review by Health Canada’s
A patented, broad-spectrum liquid chemical warfare (CW) agent decontaminant, RSDL neutralizes or removes CW agents and T2 toxin from skin on contact, leaving a non-toxic residue that can
Under the terms of the agreement, the company is entitled to receive a payment of E3 million from Merck KGaA, the global pharmaceutical and chemical company based in
Imprime PGG is a targeted immunotherapeutic drug candidate from Biothera that works synergistically with monoclonal antibodies through specific innate immune cell activation. Erbitux is an anti-tumor monoclonal antibody
The company said that it is also investigating other novel and generic drugs and promising therapeutic areas in combination with using its patented transdermal delivery system. Juliet Singh,
The Serdaxin Phase IIa study calls for the recruitment of up to 100 patients to evaluate its preliminary efficacy in treating major depressive disorder. Rexahn’s Phase IIa clinical
In this role, Dr Cheng will be responsible for Gilead’s biometrics, clinical operations, drug safety and public health, project and portfolio management, and regulatory affairs activities, reporting to
Robin Carlstein, senior vice president of advanced wound devices at Smith & Nephew, said: “Smith & Nephew welcomes the appeals court decision that our Versatile 1 negative pressure
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.